|
2023
|
Invention
|
Methods for preparing anti-human pd-1 antibody crystals and methods of use thereof. The invention... |
|
|
Invention
|
Crystalline forms of a pcsk9 inhibitor, compositions and uses. This disclosure provides crystalli... |
|
|
Invention
|
Processes for preparing oxazolidinone compounds. Mycobacteria tuberculosisMycobacteria tuberculosis. |
|
|
Invention
|
Process for preparing agglomerated crystalline medium-chain fatty acid sodium salts. The process ... |
|
2022
|
Invention
|
Synthetic pathway to belzutifan and crystalline phases of synthetic intermediates. The disclosure... |
|
2021
|
Invention
|
Process for preparing sugammadex.
The present invention relates to a process for drying crystall... |
|
|
Invention
|
Novel crystalline forms of sugammadex. The present disclosure provides a novel crystalline forms ... |
|
|
Invention
|
Crystalline form type 11 of sugammadex. The present invention relates to a process for drying cry... |
|
|
Invention
|
Novel crystalline forms of sugammadex. The present disclosure provides novel crystalline forms of... |
|
|
Invention
|
Process for preparing sugammadex. The present invention relates to a process for drying crystalli... |
|
|
Invention
|
Crystalline form type 5 of sugammadex. The present invention relates to crystalline form Type 5 o... |
|
2019
|
Invention
|
Novel crystalline forms of sugammadex.
The present invention provides a novel crystalline forms ... |
|
|
Invention
|
Novel crystalline forms of sugammadex. The present invention provides a novel crystalline forms o... |
|
|
Invention
|
Process for synthesis of a phenoxy diaminopyrimidine compound. Disclosed herein is a novel proces... |
